Razak Pharmaceutical Starts Tablet Line Under Food and Drug Administration Permit

Razak Pharmaceutical said in a Group B disclosure published on Sunday, 18 October 2026 that its general solid-dosage line 2 for tablets has begun operation. The company said the Food and Drug Administration's medicines department had permitted the launch on 8 September 2026 subject to good manufacturing practice. The filing gives no rated capacity or share of company sales for the line, so the production and revenue effect cannot yet be quantified from this letter.